Deckers Gets Marked Down

🌾 Welcome to StableBread's Newsletter!

SECSift is an EDGAR replacement I built earlier this month that turns SEC filings into clean, readable documents. You can also:

Here’s a 3-minute interactive demo (viewable on your computer) and video I made walking through the entire tool.

I've just added MCP server access, so you can use SECSift right inside Claude, ChatGPT, and other AI chats that support MCP.

You can start using the MCP today with a free account! It takes less than 30 seconds to get connected. Here's how to set it up and everything it can do.

Some ideas on what to ask SECSift:

Unlike EDGAR, SECSift gives your AI clean sections and exact tables. It pulls only what it needs and links answers to the exact passage(s) on SECSift.

Annual plans (for more AI usage, extra storage, merging tables, exporting) are 25% off with code “SB25” through August 31.

I first wrote up Deckers Brands (NYSE: DECK) on October 30, 2025, when it was ~$84/share. The stock ran to ~$120/share by late February 2026, then gave most of that gain back and now trades at ~$91/share.

This was the thesis at the time: “You can buy $1.2B in annual EBIT, $1.4B cash, $900M FCF, zero debt—with international revenue growing 38%—all for 13x earnings.”

The balance sheet is stronger now, at $1.6B of cash and $1.1B of FCF, still with zero debt. At ~$91/share the stock trades at ~12x forward earnings, just under the 13x back then because earnings kept growing.

On the other hand, international only grew 8.4% last quarter, and HOKA and UGG growth both roughly halved, from about 20% and 19% a year ago to 7.7% and 4.9%.

That deceleration, and a new question about HOKA, is why it’s worth a quick revisit.

Two brands drive almost everything, plus a couple being wound down:

The June-quarter mix is lopsided toward HOKA, but that’s seasonal. UGG is a fall/winter brand and does most of its business later in the year, so on a full-year basis the two are closer in size.

Deckers sells two ways:

That mix shift is a margin story as much as a growth one.

Deckers went from 25x earnings in early 2025 to 12x today, cut roughly in half, while EPS kept rising.

Three bear narratives drove that, and they’ve aged poorly:

The business keeps gaining share at a 20%+ operating margin and guides conservatively, yet the stock is priced like it’s done growing.

Q1 FY2027 (ended June 30, 2026) reported July 23, 2026. EPS beat consensus. Operating income and net income both fell.

The good:

The not-so-good:

Revenue grew, gross margin improved, and operating income still fell, because SG&A grew more than twice as fast as sales.

The seasonally soft June quarter always runs the lowest operating margin of the year, so a low 15.2% is expected. The 190bp decline from last year’s 17.1% matters more, because comparing June to June isolates the SG&A deleverage from seasonality.

And the EPS “growth” is manufactured. Net income fell 6.6%, but diluted EPS rose 1.1% because buybacks shrank the share count enough to flip a down number positive. The business earned less and reported more per share.

The segment numbers explain the operating-income drop:

Management raised full-year EPS guidance to $7.35-7.50 anyway, on cost discipline for the back half. The stock fell 8% regardless, on a soft Q2 guide (revenue up ~5%, EPS $1.73-1.78) and a higher tariff assumption.

The sell-off wasn’t about the June quarter. It was about what the guide implied for the rest of the year.

In last year’s June quarter, HOKA grew about 20% and UGG about 19%. This quarter: 7.7% and 4.9%. Both roughly halved:

FY26 revenue grew 9.8%, the first sub-10% year after five straight double-digit years. The five years through FY25 delivered a 19% revenue CAGR and a 32% EPS CAGR.

The double-digit era is over, and the FY27 guide of $5.86-5.91B is high-single-digit.

Management still guides HOKA to low-double-digit and UGG to mid-single-digit growth for the year, with both accelerating in the second half.

The bull explanation is a timing shift in European wholesale that held back Q1 and reverses in H2, plus a long international runway (20-25 new HOKA stores/year abroad).

The bear explanation is simpler. You may be watching a great brand mature, and the guide leans on a back-half recovery that has to show up.

HOKA’s DTC channel grew 17% and full-price selling held. Direct demand is holding, and the slowdown is mostly in wholesale.

Gross margin isn’t the problem. As the quarter showed, it’s rising, and the FY27 guide keeps it above 56.5%. The pressure is below it, in SG&A and tariffs.

Deckers sources heavily from Asia and raised its go-forward tariff assumption to 12.5%, up from 10%.

That, plus the SG&A growth, is why FY27 operating margin is guided to 21.5%, down from 23.1% in FY26. Still great for footwear (Nike’s is lower and falling, most peers sit in the low-to-mid teens), but a clear step down.

Some of the SG&A pressure is deliberate. Deckers extended the lease on its Moreno Valley distribution center and kept building stores, adding $120.1M of operating lease assets in the quarter.

That expands capacity for more volume, and the added occupancy runs through SG&A.

There’s also an upside item the guidance leaves out. In February 2026 the Supreme Court struck down the IEEPA tariffs, and a federal court ordered refunds of what had already been collected.

The administration replaced them with tariffs under other authority, so Deckers still pays going forward, which is why the 12.5% assumption stands.

But Deckers had paid ~$120M in the old IEEPA tariffs and began filing to claw it back after quarter-end. None of it’s recognized yet, and the net will land below $120M after cost-sharing with manufacturers and taxes.

It’s a cash refund that sits outside the numbers and the guidance, against a company earning ~$1B/year.

Deckers doesn’t issue dividends. Cash goes back entirely through repurchases, and the pace has noticeably ramped:

The board added $3.5B to the authorization in May 2026, leaving $4.7B available as of June 30, ~38% of the ~$12.5B market cap.

The buyback comes with two caveats:

Regardless, buying ~80% of FCF (the guide’s assumption) shrinks the share count by ~7%/year at these prices, and gets more accretive the lower the stock goes.

HOKA charges $150-200 a pair, and that premium leans on its credibility as a performance running brand. The question is whether it holds as HOKA turns into an everyday shoe for walkers and commuters.

On running forums, HOKA owners have flagged foam going dead early, outsoles wearing fast, and uppers not holding up for years, alongside a longer-running view that build quality slipped as the brand scaled.

But this appears to be an enthusiast-core complaint, and the fact is that HOKA now sells to a much broader buyer. It’s an everyday shoe for nurses, travelers, and walkers, not just runners.

The bull case is that this wider demand swamps any enthusiast defection, and the 17% DTC growth with full-price selling intact says it’s working so far.

The bear case is that losing the enthusiast core is an early warning, not a present problem. After all, performance credibility is what lets a running brand charge $150-200 and resist discounts.

Trade that credibility for ubiquity and the premium erodes, and pricing power with it. That’s arguably part of what happened to Nike.

The segment numbers fit the bear case. HOKA grew sales 7.7% but generated almost no incremental operating profit, and UGG needed heavier marketing to hold its growth.

That can be read innocently, as mix and investment spend, or as an early sign it costs more to move the same volume. Neither reading is entirely proven yet.

The metric to watch is whether HOKA holds full-price DTC growth as the newness wears off. If the complaints start showing up as heavier promotions or slowing DTC, the margin and the multiple compress together.

At $91.00/share, Deckers trades at 12.9x trailing earnings ($7.03 TTM EPS) and 12.3x the FY27 guide midpoint of $7.42. It’s ~8x EBITDA on enterprise value and ~2.3x sales on market cap, with a ~9% FCF yield and ~40% ROE.

Against its own history, this is a business that compounded EPS at a 32% five-year CAGR and still guides to low-to-mid double-digit EPS growth, trading at a low-teens multiple after historically fetching 20-25x.

Against peers, Nike (NKE) trades near 30x depressed turnaround earnings and On (ONON) carries a multiple several times Deckers’, while Deckers out-earns both on margin and return.

Skechers, the other cheap footwear name, was taken private by 3G Capital in 2025.

Here’s a simple but practical valuation analysis:

Wall Street’s average target is $123, ~35% above the stock, and even the most bearish target ($85, Wells Fargo at Underweight) sits only ~7% below today’s price.

Most analysts trimmed targets after the soft Q2 guide, but the average stayed well above the price. Consensus is still a Buy.

That upside may not excite you, but the balance sheet limits the downside. Deckers holds ~$1.6B of cash and no debt, ~$11.70/share in net cash.

FCF runs ~$1.1B/year, or ~$8.00/share. Strip out the net cash and the market is already paying just 10x FCF for the operating business, the low end of branded footwear.

A genuine washout at 7x FCF plus the cash still gets you ~$68/share ($8.00 × 7x + $11.70), ~26% below today.

So at $91/share you’re paying a low-end multiple for a business that is still growing and still earning great margins. That floor moves with FCF, and it drops if margins keep compressing.

Deckers (DECK) at $91/share is a two-brand, share-gaining business with a 20%+ operating margin, ~40% ROE, ~$1.6B of net cash, no debt, ~$1.1B of FCF, and a buyback worth ~38% of the company, at ~12x earnings.

The bull case holds up on almost every number. The bear case rests on two main factors:

The financials say cheap compounder. The falling operating margin and the HOKA question ask whether the compounding lasts.

At 12x, the market is siding with the bears, and it hands you a balance-sheet floor while you wait to find out who’s right.

What I’d watch isn’t the headline growth rate. It’s HOKA’s full-price DTC trend, the promotional cadence, and the operating margin line:

At $91/share, the market is already pricing a stall. The upside is the business proving it’s still compounding.

So am I buying it here?